These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1020 related articles for article (PubMed ID: 9394030)
1. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers. Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
4. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys. Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329 [TBL] [Abstract][Full Text] [Related]
5. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C; Kamel A; Gummerus J; Wilner K Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781 [TBL] [Abstract][Full Text] [Related]
6. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats. Johnson KA; Prakash C Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349 [TBL] [Abstract][Full Text] [Related]
7. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Prakash C; Cui D; Potchoiba MJ; Butler T Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205 [TBL] [Abstract][Full Text] [Related]
8. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy. Colizza K; Awad M; Kamel A Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832 [TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851 [TBL] [Abstract][Full Text] [Related]
10. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related]
11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
12. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone. Prakash C; Kamel A; Anderson W; Howard H Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052 [TBL] [Abstract][Full Text] [Related]
13. Identification of the metabolites of the HIV-1 reverse transcriptase inhibitor delavirdine in monkeys. Chang M; Sood VK; Kloosterman DA; Hauer MJ; Fagerness PE; Sanders PE; Vrbanac JJ Drug Metab Dispos; 1997 Jul; 25(7):814-27. PubMed ID: 9224776 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys. Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052 [TBL] [Abstract][Full Text] [Related]
15. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]-pyrimidin-4-one (SK3530) in rats. Lee J; Yoo HH; Rhim KJ; Sohn DR; Kim DH Rapid Commun Mass Spectrom; 2007; 21(7):1139-49. PubMed ID: 17318927 [TBL] [Abstract][Full Text] [Related]
17. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241 [TBL] [Abstract][Full Text] [Related]
18. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans. Balani SK; Woolf EJ; Hoagland VL; Sturgill MG; Deutsch PJ; Yeh KC; Lin JH Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147 [TBL] [Abstract][Full Text] [Related]
19. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
20. Excretion and metabolism of trovafloxacin in humans. Dalvie DK; Khosla N; Vincent J Drug Metab Dispos; 1997 Apr; 25(4):423-7. PubMed ID: 9107540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]